Close Menu

biomarker detection

Researchers from Germany and the US compared soluble TREM2 levels in people with autosomal dominant Alzheimer's disease and their unaffected siblings.

The company is in the beginning stages of product development, but is confident that it has a product that will be successful in the early diagnostics market.